Ashley Cordova - 27 Feb 2026 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Former Chief Executive Officer
Signature
Steven Robbins, as attorney in fact for Cordova, Ashley
Issuer symbol
NVCR
Transactions as of
27 Feb 2026
Net transactions value
-$290,440
Form type
4
Filing time
03 Mar 2026, 16:09:18 UTC
Previous filing
08 Sep 2025
Next filing
05 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cordova Ashley Former Chief Executive Officer C/O NOVOCURE INC., 1550 LIBERTY RIDGE DRIVE, SUITE 115, WAYNE Steven Robbins, as attorney in fact for Cordova, Ashley 03 Mar 2026 0001822014

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Tax liability $158,689 -11,541 -2.6% $13.75 426,028 27 Feb 2026 Direct F1
transaction NVCR Ordinary Shares Award $0 +23,818 +5.6% $0.000000 449,846 28 Feb 2026 Direct F2
transaction NVCR Ordinary Shares Tax liability $32,945 -2,410 -0.54% $13.67 447,436 02 Mar 2026 Direct F1
transaction NVCR Ordinary Shares Tax liability $98,807 -7,228 -1.6% $13.67 440,208 02 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Ashley Cordova is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1).
F2 Represents vesting of performance-based restricted stock units.